The irradiation of blood and blood components to prevent graft-versus-host disease: Technical issues and guidelines

1997 ◽  
Vol 11 (1) ◽  
pp. 15-26 ◽  
Author(s):  
Gary Moroff ◽  
N.L.C. Luban
1996 ◽  
Vol 6 (3) ◽  
pp. 261-271 ◽  
Author(s):  
J. Chapman ◽  
R. D. Finney ◽  
K. Forman ◽  
P. Kelsey ◽  
S. M. Knowles ◽  
...  

2021 ◽  
Vol 13 (3) ◽  
Author(s):  
Palma Manduzio

Dear Editor, A recent paper from Dr Elliot published in Transfusion, entitled ‘Missed irradiation of cellular blood components from vulnerable patients: Insight from 10 years of SHOT data’ updates on Transfusion-associated graft-versus-host disease and blood safety [...].


1996 ◽  
Vol 6 (3) ◽  
pp. 222-227 ◽  
Author(s):  
Rodney C. G. Franklin ◽  
Obed Onuzo ◽  
Paul A. Miller ◽  
David Goldblatt ◽  
David Cummins

SummaryMost patients with DiGeorge syndrome require surgery to their heart defect during infancy and are at risk of developing transfusion-associated graft-versus-host disease if non-irradiated blood is used perioperatively. Because of its wide clinical variability, DiGeorge syndrome may not be recognized before surgery and thus a high level of vigilance is required. An infant is described who developed fatal graft-versus-host disease after receiving non-irradiated blood components during surgery for classical tetralogy of Fallot; the postoperative clinical course and autopsy findings were consistent with underlying DiGeorge syndrome. An informal survey of the 18 pediatric cardiology units in the United Kingdom and the Republic of Ireland showed no consensus as to which patients should be screened for DiGeorge syndrome, which screening test to use and to whom irradiated blood components should or should not be given to prevent transfusion associated graft-versus-host disease. Assessment of T-cell numbers appears to be the preferred screening method to determine those who might benefit from receiving such therapy.


Sign in / Sign up

Export Citation Format

Share Document